Table 3.

Estimated CD4 slope (cells/μL/year) by duration of treatment and HIV VL.

Month since cART initiation	HIV VL level (copies/mL)
	500	1 000	2 000	3 000	4 000	5 000	10 000	20 000	30 000	40 000	50 000	100 000	150 000
	Patient 1, 30 years old, no hepatitis coinfection, no AIDS defining illness, and current CD4 200 cells per μL
6-12	85.6	73.4	61.2	54.1	49.0	45.1	32.9	20.7	13.6	8.5	4.6	-7.6	-14.7
12-18	64.1	51.9	39.7	32.6	27.5	23.6	11.4	-0.8	-7.9	-13.0	-16.9	-29.1	-36.2
18-24	59.8	47.6	35.4	28.3	23.2	19.3	7.1	-5.1	-12.2	-17.3	-21.2	-33.4	-40.5
24+	26.5	14.3	2.1	-5.0	-10.1	-14.0	-26.2	-38.4	-45.5	-50.6	-54.5	-66.7	-73.8
	Patient 2, 30 years old, coinfected with hepatitis, no AIDS defining illness, and current CD4 200 cells per μL
6-12	67.9	55.7	43.5	36.4	31.3	27.4	15.2	3.0	-4.1	-9.2	-13.1	-25.3	-32.4
12-18	46.4	34.2	22.0	14.9	9.8	5.9	-6.3	-18.5	-25.6	-30.7	-34.6	-46.8	-53.9
18-24	42.1	29.9	17.7	10.6	5.5	1.6	-10.6	-22.8	-29.9	-35.0	-38.9	-51.1	-58.2
24+	8.8	-3.4	-15.6	-22.7	-27.8	-31.7	-43.9	-56.1	-63.2	-68.3	-72.2	-84.4	-91.5